Acute Graft Versus Host Disease Clinical Trials in Hangzhou, Zhejiang
4 recruitingHangzhou, Zhejiang, China
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
First-Line Jaktinib for Acute Graft-Versus-Host Disease (aGVHD)
Acute Graft Versus Host Disease
First Affiliated Hospital of Zhejiang University35 enrolled1 locationNCT07285889
Recruiting
Phase 4
Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease
Steroid-refractory Acute Graft Versus Host Disease
Novartis Pharmaceuticals36 enrolled17 locationsNCT06462469
Recruiting
Phase 3
Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases
Acute Graft Versus Host Disease
Anhui Provincial Hospital198 enrolled6 locationsNCT06294691
Recruiting
Phase 1
Universal CNK-UT Therapy for Refractory aGVHD
Acute Graft Versus Host Disease
First Affiliated Hospital of Zhejiang University23 enrolled2 locationsNCT06750133